Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
Kiniksa Pharmaceuticals (KNSA) Ownership Overview
7.13% Insiders
16.17% Mutual Funds
36.92% Other Institutional Investors
10.63% ETFs
29.16% Public Companies and
Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 63.72% of the company’s stock is owned by Institutional Investors, 7.13% is owned by Insiders, and 29.16% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 14, 2025 | xxxxxxxxxxxxx | $5859815 | |
Jun 11, 2025 | xxxxxxxxxxxxx | $833001 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $534600 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $11025052 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $26104113 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $54437130 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,826,246 | Institution | 6.16% | 129,385,542 | |
| 2,768,496 | Insider | 6.03% | 126,741,747 | |
| 2,765,652 | Institution | 6.03% | 126,611,549 | |
| 2,671,138 | Institution | 5.82% | 122,284,698 | |
| 1,400,972 | Institution | 3.05% | 64,136,498 | |
| 1,319,688 | Institution | 2.88% | 60,415,317 | |
| 714,964 | Institution | 1.56% | 32,731,052 | |
| 632,827 | Institution | 1.38% | 28,970,820 | |
| 389,911 | Institution | 0.85% | 17,850,126 | |
| 350,000 | Institution | 0.76% | 16,023,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,671,138 | Institution | 5.82% | 122,284,698 | |
| 714,964 | Institution | 1.56% | 32,731,052 | |
| 389,911 | Institution | 0.85% | 17,850,126 | |
| 350,000 | Institution | 0.76% | 16,023,000 | |
| 332,836 | Institution | 0.73% | 15,237,232 | |
| 332,448 | Institution | 0.72% | 15,219,469 | |
| 311,881 | Institution | 0.68% | 14,277,912 | |
| 264,751 | Institution | 0.58% | 12,120,301 | |
| 154,472 | Institution | 0.34% | 7,071,728 | |
| 145,000 | Institution | 0.32% | 6,638,100 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,227,878 | Institution | 2.68% | 53,928,402 | |
| 920,574 | Institution | 2.01% | 40,431,610 | |
| 511,979 | Institution | 1.12% | 22,486,118 | |
| 231,931 | Institution | 0.51% | 10,685,061 | |
| 231,931 | Institution | 0.51% | 10,685,061 | |
| 140,266 | Institution | 0.31% | 6,462,055 | |
| 140,266 | Institution | 0.31% | 6,462,055 | |
| 140,266 | Institution | 0.31% | 6,462,055 | |
| 132,392 | Institution | 0.29% | 6,099,299 | |
| 124,850 | Institution | 0.27% | 5,751,840 |
FAQ
Who Owns Kiniksa Pharmaceuticals (KNSA)?
According to the latest TipRanks data, approximately 36.92% of the company's stock is held by institutional investors, 7.13% is held by insiders, and 29.16% is held by retail investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.92% of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.16% of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors.
Who owns the most shares of Kiniksa Pharmaceuticals (KNSA)?
Felix Baker owns the most shares of Kiniksa Pharmaceuticals (KNSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.